Kim Hye Sung, Gupta Rohit, Rali Parth
Department of Medicine Temple University Hospital Philadelphia Pennsylvania USA.
Northwestern University Feinberg School of Medicine Chicago Illinois USA.
Pulm Circ. 2025 Mar 11;15(1):e70056. doi: 10.1002/pul2.70056. eCollection 2025 Jan.
Pulmonary embolism (PE) is a leading cause of mortality in lung transplant recipients, with early cases associated with particularly poor outcomes. Identified risk factors include elevated BMI, renal dysfunction, ABO mismatch, donor malignancy, and specific immunosuppressive agents. Tailored risk assessments and targeted interventions are essential to mitigating PE-related mortality.
肺栓塞(PE)是肺移植受者死亡的主要原因,早期病例的预后尤其差。已确定的风险因素包括体重指数升高、肾功能不全、ABO血型不匹配、供体恶性肿瘤以及特定的免疫抑制剂。定制的风险评估和有针对性的干预对于降低与PE相关的死亡率至关重要。